Zobrazeno 1 - 3
of 3
pro vyhledávání: '"David K. Sahner"'
Autor:
Hythem Sidky, Kristen A. Hansen, Andrew T. Girvin, Nathan Hotaling, Sam G. Michael, Ken Gersing, David K. Sahner
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 24, Iss , Pp 115-125 (2024)
Background: Post-acute sequelae of COVID-19 (PASC) produce significant morbidity, prompting evaluation of interventions that might lower risk. Selective serotonin reuptake inhibitors (SSRIs) potentially could modulate risk of PASC via their central,
Externí odkaz:
https://doaj.org/article/c0703b56ad684394a97e3a2666d7049f
Autor:
Arjun S. Yadaw, Behdad Afzali, Nathan Hotaling, Hythem Sidky, Emily R Pfaff, David K. Sahner, Ewy A. Mathé
Publikováno v:
medRxiv
ImportanceIdentifying individuals with a higher risk of developing severe COVID-19 outcomes will inform targeted or more intensive clinical monitoring and management.ObjectiveTo examine, using data from the National COVID Cohort Collaborative (N3C),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2cc4ac472b5dab4ef0c36be437fea0
https://europepmc.org/articles/PMC9915827/
https://europepmc.org/articles/PMC9915827/
Autor:
David K. Sahner, Anne Marie Duliege, James O. Kahn, Martin A. Giedlin, Andrew T. Pavia, Robin L. Dewar, Robert L. Murphy, Doreen G. Chaitt, Stephen L. Boswell, Wai Ping Leong, Richard T. Davey, H. Clifford Lane, Margarita Cancio, Frank M. Graziano, Jeffrey P. Nadler, William B. Capra
Publikováno v:
JAMA. 284:183
ContextWhile interleukin 2 (IL-2) is capable of inducing a marked expansion of the CD4 T-lymphocyte pool, limited data exist on whether IL-2 treatment can add significantly to the immunologic and virologic effects of potent antiretroviral therapy (AR